Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Paul W. Noble, M.D., of Cedars-Sinai in Los Angeles, and Paul Frohna, M.D., Ph.D., of Endeavor BioMedicines, discussed the ...

Stem cell clinics have popped up throughout California, promising cures and relief for arthritis, Alzheimer’s and other ...

ROACH: I'm a 67-year-old healthy male, but I do take Humira for rheumatoid arthritis (RA). It does a wonderful job for me with no side effects. It does such a good job that I can periodically extend ...

Discover the crucial connection between body weight and arthritis. Learn how excess weight accelerates joint degeneration, ...

Targeted therapies for PsA are effective for reducing the use of symptomatic treatments, sick leave, and rates of hospitalization.

Learn about CYP suppression, immunomodulators, and how to identify DDR risks using studies on CYP suppression.

In autoimmune rheumatic diseases, various components of the respiratory tract, including the parenchyma, vessels, airways, ...

Plus: Here’s how Epic founder and CEO Judy Faulkner will keep her medical records company private, independent and ...

Despite keen interest in BAFF-R inhibition, rheumatologists favor BMS’ Sotyktu (deucravacitinib) as the leading therapy in development for Sjögren’s.EXTON, PA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- ...

Big Pharma had the money, but what they didn’t have was the power of over 50 million seniors who put their feet down and said “enough is enough.” ...

A top California health plan is set to offer one of the world’s biggest-selling drugs for free in a bid to show the medicine can reach Americans affordably without going through the middlemen that ...